2016 Top Story- Archives -
John Landers, PhD, led a team of more than 80 scientists who found that variations in a gene with multiple functions in neurons are present in approximately 3 percent of all cases of ALS in North American and European populations, both sporadic and familial.
On Match Day, 116 students from the School of Medicine Class of 2016 discovered where they will spend their residencies, with 81 students representing 68 percent of the class entering primary care.
Shan Lu, MD, PhD, has received $17.3 million from the National Institute of Allergy and Infectious Diseases to develop and produce an optimized HIV vaccine to be used in Phase II human clinical trials.
Top Story: Viral infection during pregnancy causes autism-like behaviors in mice by triggering key immune reaction
A new study found that activation of a particular immune response in pregnant mice alters the brain structure of the mouse offspring and causes behavioral changes reminiscent of those observed in humans with autism. The research was published in Science. Jun Huh, PhD, is a corresponding author.
Vladimir Litvak, PhD, and colleagues made a startling discovery that immune system signaling can directly affect social behavior. Published in Nature, these findings could have great implications for neurological diseases such as autism-spectrum disorders and schizophrenia.
With a three-year, $2.1 million grant, the GSN is launching the Central Massachusetts Advanced Nursing Education Academic-Practice Partnership to better prepare advanced practice nurses to work in underserved communities.
A new veteran’s health class for medical and nursing students at UMass Medical School focuses on the unique and complex health care needs of Americans who have served their country.
Geriatric palliative care experts Jennifer Tjia, MD, MSCE, and Kate Lapane, PhD, discuss the use of beta-blockers among elderly adults in an editorial published in JAMA Internal Medicine.
Researchers at UMass Medical School and the University of Toronto have discovered the first known “off-switches” for CRISPR/Cas9 genome editing, providing much greater control over the edits, according to a new study published in Cell. Erik Sontheimer, PhD, led the research at UMMS.
The UMass Medical School community is saddened by the death of the founding chair of neurology, David A. Drachman, MD, professor and chair emeritus of neurology. Dr. Drachman died Dec. 5. He was 84.